Trials / Sponsors / Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.
Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Evaluate the Safety and Pharmacokinetics of Ricolinostat Peripheral Nervous System Diseases | Phase 1 | 2022-01-12 |
| Completed | A Study to Investigate the Safety and Efficacy of Ricolinostat Peripheral Nervous System Diseases | Phase 1 | 2022-01-01 |
| Completed | Pre-study to Evaluate IENFD Induction in Patients With Taxane-induced CIPN Peripheral Nervous System Diseases | — | 2021-10-12 |